GenBio Inc. A USA 💊 Biotechnology Co. Launches On TruCrowd

---

View this email in your browser

---

GenBio Inc. Is pleased to announce
An equity crowdfunding round on:

GenBio Inc. is an early-stage US Biotech Company with the necessary research expertise to develop the next generation of anti-inflammatory drugs. A very rare opportunity presents itself to invest in a pioneering and ground-breaking highly specialized US scientific team and potentially reap significant rewards.

The Problem

• Current medications invariably confer significant toxicity issues and concerns that can seriously impact on consumers' health.
• There are also increasing worries about antimicrobial resistance weakening the effectiveness of drugs, especially antibiotics.
• The world is urgently seeking the next generation of anti-inflammatory drugs to combat these growing concerns.

The solution

• GenBio is developing an entirely new class of more potent, yet far less toxic anti-inflammatory drugs
• First company in the world to identify, then research a unique extremely rare natural extract demonstrating healthcare benefits no other extract could ever hope to match
• Also, only Company in world to bring extract to USA for further research, resulting in a dramatic discovery by US scientists of its unique capabilities to treat a variety of ailments way more effectively and yet with fewer side effects.
• This 'world first' research discovery insight has important ramifications for an entirely new generation of anti-inflammatory drugs to replace some current prescription medications
• Successful research and the resulting patenting of these molecules and drugs will create a near monopoly of entirely new classes of pharmaceutical natural health and nutraceutical products

Exit Strategy

We expect a sale of all assets within 12-18 months at a price that reflects the uniqueness of our research into novel patented anti-inflammatory drugs. The company should be a compelling acquisition opportunity for a major pharmaceutical company in the inflammation and anti-infective field.

(CLICK INVEST NOW TO GO TO OFFERING PAGE)

Investors can now invest in GenBio via credit card on TruCrowd @GenBioUSA Inc. Is entering 191B Anti-inflammatory Market #LIVE on @truCrowd. #SEC #RegCF Allows GenBio To Offer Shares To The Public @ $2.00 Per Share
(Min. Investment $250.00)
Join us Today! https://us.trucrowd.com/equity/offer-summary/GenBio




(Your Investment Can Now Be Made By Credit Card)

---

This email was sent to alexiadodd9.dodd@blogger.com
You can Update Your Preferences or Unsubscribe from this list.

GenBio Inc. · 23411 Summerfield #22C · Aliso Viejo · · California · 92656 · United States

---

Powered by Zendable
Try for Free